Corvia Medical, Inc., is dedicated to revolutionizing the treatment of heart failure with first-in-class structural heart devices. The company has developed the world’s first transcatheter device designed to treat heart failure with preserved (HFpEF) or mid-range (HFmrEF), ejection fraction, previously known as diastolic heart failure (DHF). The innovative InterAtrial Shunt Device (IASD®) is designed to reduce elevated left atrial pressure (LAp), which is the main cause of heart failure symptoms.
Corvia Medical is enrolling patients in the REDUCE LAP-HF IV Study. To learn more, visit treatmyheartfailure.com.
Patients Eager to Test Device That Could Ease Heart Failure Symptoms
Ohio State Evaluates First Transcatheter Implant for Diastolic Heart Failure